retatrutide and joint pain (Eli Lilly's triple GLP-1/GIP/Glucagon receptor agonist) just delivered the most impressive obesity + osteoarthritis data we've ever seen in the phase 3 TRIUMPH-4 trial: Retatrutide: Is It The Next

Although studies in animal models have shown that GLP-1R agonists reduce Aaccumulation and tau hyperphosphorylation, few human studies have evaluated these effects

Glutathione-S-transferase (GST) is a highly soluble and stable 26 kDa enzyme that catalyzes the protective mechanisms of Glutathione (GSH)

A damaged skin barrier often looks red, irritated, and dehydrated, even if your skin is naturally oily

Cardiovascular protective properties of GLP-1 receptor agonists: more than just diabetic and weight loss drugs

Reduction of Abdominal and Visceral Fat : Animal and early human models have demonstrated a preferential reduction of abdominal fat following subcutaneous administration of AOD-9604